tradingkey.logo

Cibus Inc reports results for the quarter ended June 30 - Earnings Summary

ReutersAug 14, 2025 9:01 PM
  • Cibus Inc CBUS.OQ reported a quarterly adjusted loss of 61 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-1.14. The mean expectation of four analysts for the quarter was for a loss of 69 cents per share. Wall Street expected results to range from -86 cents to -44 cents per share.

  • Revenue rose 11.3% to $933.00 thousand from a year ago; analysts expected $1.15 million.

  • Cibus Inc's reported EPS for the quarter was a loss of 61 cents​.

  • The company reported a quarterly loss of $25.37 million.

  • Cibus Inc shares had risen by 2.9% this quarter and lost 48.9% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had risen by about 15.4% in the last three months.​

  • In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

  • Wall Street's median 12-month price target for Cibus Inc is $19.25, about 92.6% above its last closing price of $1.42

This summary was machine generated from LSEG data August 14 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Jun. 30 2025

-0.69

-0.61

Beat

Mar. 31 2025

-0.66

-0.74

Missed

Dec. 31 2024

-0.75

-0.87

Missed

Sep. 30 2024

-0.89

0.06

Beat

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI